Moderna 's ( MRNA 3.13%) wild success in the COVID-19 vaccine market has worn off. The company's revenue, earnings, and stock ...

After falling off their perch in the last few months of 2024, European healthcare stocks head into a new year facing the ...

To understand how Summit Therapeutics ( SMMT 8.36%) could turn an investment of $1,000 into $5,000 by 2030, we need to first ...

We present three small biotech stocks, which according to Wall Street analysts, have upside potential for 2025.

Bird flu has emerged as a critical public health concern in California, with Governor Gavin Newsom declaring a state of ...

Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. Pfizer stock and other vaccine shares tumbled Friday ...

Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. Pfizer stock and other vaccine shares tumbled Friday morning ...

Stocks in the value sector ... BioNTech played a huge part in formulating the BioNTech-Pfizer vaccine - the most effective COVID-19 vaccine in the world. BioNTech will continue to see strong ...

Lilly investors got the jitters, saw better opportunities elsewhere, or decided to hold onto their chips. In the third ...

A secretary turned $180 into $7.2 million by holding her employer's stock for 75 years Why I Just Bought More of These 3 Top Dividend Stocks in My Retirement Account and Plan to Keep Adding in ...

Let's explore two healthcare sector dividend stocks that could make a fantastic addition to your ... Pfizer has struggled in ...